The Clorox Company : Good timing to anticipate a continuation of the trend
Entry price | Target | Stop-loss | Potential |
---|
US$133.42 |
US$139.9 |
US$128.9 |
+4.85% |
---|
Shares in Clorox Co show a positive technical chart pattern over the medium term. The timing to jump back on the rising trend seems good.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● The tendency within the weekly time frame is positive above the technical support level at 122.45 USD
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at USD 138.37.
● The company's enterprise value to sales, at 3.2 times its current sales, is high.
● Most analysts recommend that the stock should be sold or reduced.
● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.